• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

致病的口腔-肠道-肝脏轴:新的认识和临床意义。

The pathogenic oral-gut-liver axis: new understandings and clinical implications.

机构信息

Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, United States.

Division of Gastroenterology and Hepatology, Department of Internal Medicine, Tokai University School of Medicine, Isehara, Japan.

出版信息

Expert Rev Clin Immunol. 2021 Jul;17(7):727-736. doi: 10.1080/1744666X.2021.1935877. Epub 2021 Jun 8.

DOI:10.1080/1744666X.2021.1935877
PMID:34057877
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8416698/
Abstract

INTRODUCTION

Oral health is closely related to extra-oral disease status, as may be represented by the manifestations of gastrointestinal and liver diseases.

AREAS COVERED

This review focuses on the roles that the oral-gut or the oral-gut-liver axis play in the pathogenesis of inflammatory bowel disease, colorectal cancer, metabolic fatty liver disease, and nonalcoholic steatohepatitis. The discussion will begin with clinical data, including data from preclinical animal models, to elucidate mechanisms. We will also discuss ways to target oral dysbiosis and oral inflammation to treat gastrointestinal and liver diseases.

EXPERT OPINION

Several studies have demonstrated that oral pathobionts can translocate to the gastrointestinal tract where they contribute to inflammation and tumorigenesis. Furthermore, oral bacteria that migrate to the gastrointestinal tract can disseminate to the liver and cause hepatic disease. Thus, oral bacteria that ectopically colonize the intestine may serve as biomarkers for gastrointestinal and liver diseases. Also, understanding the characteristics of the oral-gut and oral-gut-liver microbial and immune axes will provide new insights into the pathogenesis of these diseases.

摘要

简介

口腔健康与口腔外疾病状况密切相关,例如胃肠道和肝脏疾病的表现。

涵盖领域

本综述重点介绍了口腔-肠道或口腔-肠道-肝脏轴在炎症性肠病、结直肠癌、代谢性脂肪性肝病和非酒精性脂肪性肝炎发病机制中的作用。讨论将从临床数据开始,包括来自临床前动物模型的数据,以阐明机制。我们还将讨论针对口腔菌群失调和口腔炎症来治疗胃肠道和肝脏疾病的方法。

专家意见

几项研究表明,口腔条件致病菌可以易位到胃肠道,从而导致炎症和肿瘤发生。此外,迁移到胃肠道的口腔细菌可以传播到肝脏并引起肝脏疾病。因此,异位定植于肠道的口腔细菌可作为胃肠道和肝脏疾病的生物标志物。此外,了解口腔-肠道和口腔-肠道-肝脏微生物和免疫轴的特征将为这些疾病的发病机制提供新的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46c2/8416698/07deaad343d3/nihms-1711119-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46c2/8416698/f061b7040674/nihms-1711119-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46c2/8416698/07deaad343d3/nihms-1711119-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46c2/8416698/f061b7040674/nihms-1711119-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46c2/8416698/07deaad343d3/nihms-1711119-f0002.jpg

相似文献

1
The pathogenic oral-gut-liver axis: new understandings and clinical implications.致病的口腔-肠道-肝脏轴:新的认识和临床意义。
Expert Rev Clin Immunol. 2021 Jul;17(7):727-736. doi: 10.1080/1744666X.2021.1935877. Epub 2021 Jun 8.
2
Periodontal treatment and microbiome-targeted therapy in management of periodontitis-related nonalcoholic fatty liver disease with oral and gut dysbiosis.口腔和肠道菌群失调与牙周炎相关非酒精性脂肪性肝病的牙周治疗和微生物组靶向治疗。
World J Gastroenterol. 2023 Feb 14;29(6):967-996. doi: 10.3748/wjg.v29.i6.967.
3
Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease.肠道微生物群:非酒精性脂肪性肝病的新治疗靶点。
Expert Rev Gastroenterol Hepatol. 2019 Mar;13(3):193-204. doi: 10.1080/17474124.2019.1569513. Epub 2019 Jan 25.
4
Oral and Gut Microbial Dysbiosis and Non-alcoholic Fatty Liver Disease: The Central Role of .口腔与肠道微生物失调与非酒精性脂肪性肝病:……的核心作用
Front Med (Lausanne). 2022 Mar 2;9:822190. doi: 10.3389/fmed.2022.822190. eCollection 2022.
5
Gut microbiota mediated molecular events and therapy in liver diseases.肠道微生物群介导的肝脏疾病分子事件与治疗
World J Gastroenterol. 2020 Dec 28;26(48):7603-7618. doi: 10.3748/wjg.v26.i48.7603.
6
Intestinal microbiota and nonalcoholic steatohepatitis.肠道微生物群与非酒精性脂肪性肝炎
Curr Opin Gastroenterol. 2017 May;33(3):128-133. doi: 10.1097/MOG.0000000000000349.
7
Current Research on the Pathogenesis of NAFLD/NASH and the Gut-Liver Axis: Gut Microbiota, Dysbiosis, and Leaky-Gut Syndrome.非酒精性脂肪性肝病/非酒精性脂肪性肝炎发病机制及肠-肝轴的研究进展:肠道微生物群、失调和肠漏综合征。
Int J Mol Sci. 2022 Oct 2;23(19):11689. doi: 10.3390/ijms231911689.
8
Gut Microbiota-Related Cellular and Molecular Mechanisms in the Progression of Nonalcoholic Fatty Liver Disease.肠道微生物群相关的细胞和分子机制在非酒精性脂肪性肝病进展中的作用。
Cells. 2021 Oct 2;10(10):2634. doi: 10.3390/cells10102634.
9
Role of Probiotics in Non-alcoholic Fatty Liver Disease: Does Gut Microbiota Matter?益生菌在非酒精性脂肪性肝病中的作用:肠道微生物组是否重要?
Nutrients. 2019 Nov 19;11(11):2837. doi: 10.3390/nu11112837.
10
New insights and therapeutic implication of gut microbiota in non-alcoholic fatty liver disease and its associated liver cancer.肠道微生物群在非酒精性脂肪性肝病及其相关肝癌中的新见解和治疗意义。
Cancer Lett. 2019 Sep 10;459:186-191. doi: 10.1016/j.canlet.2019.114425. Epub 2019 Jun 8.

引用本文的文献

1
Oral microbiome contributions to metabolic syndrome pathogenesis.口腔微生物群对代谢综合征发病机制的影响。
Front Microbiol. 2025 Aug 8;16:1630828. doi: 10.3389/fmicb.2025.1630828. eCollection 2025.
2
Exploring the Gut and Oral Microbiomes in Psychoactive Substance Use: A Scoping Review of Clinical Studies.探索精神活性物质使用中的肠道和口腔微生物群:临床研究的范围综述
J Neurochem. 2025 Jul;169(7):e70165. doi: 10.1111/jnc.70165.
3
Research progress on fecal microbiota transplantation in tumor prevention and treatment.粪便微生物群移植在肿瘤防治中的研究进展

本文引用的文献

1
The role of gastrointestinal pathogens in inflammatory bowel disease: a systematic review.胃肠道病原体在炎症性肠病中的作用:一项系统综述
Therap Adv Gastroenterol. 2021 Mar 31;14:17562848211004493. doi: 10.1177/17562848211004493. eCollection 2021.
2
Ingestion of Porphyromonas gingivalis exacerbates colitis via intestinal epithelial barrier disruption in mice.牙龈卟啉单胞菌摄入通过破坏肠道上皮屏障加重小鼠结肠炎。
J Periodontal Res. 2021 Apr;56(2):275-288. doi: 10.1111/jre.12816. Epub 2021 Jan 29.
3
Gut microbiota and their metabolites in the progression of non-alcoholic fatty liver disease.
Open Life Sci. 2025 Apr 1;20(1):20220954. doi: 10.1515/biol-2022-0954. eCollection 2025.
4
Sucrose-preferring gut microbes prevent host obesity by producing exopolysaccharides.偏好蔗糖的肠道微生物通过产生胞外多糖来预防宿主肥胖。
Nat Commun. 2025 Jan 29;16(1):1145. doi: 10.1038/s41467-025-56470-0.
5
The involvement of oral bacteria in inflammatory bowel disease.口腔细菌与炎症性肠病的关联。
Gastroenterol Rep (Oxf). 2024 Aug 26;12:goae076. doi: 10.1093/gastro/goae076. eCollection 2024.
6
Oral Pathogenic Bacteria and the Oral-Gut-Liver Axis: A New Understanding of Chronic Liver Diseases.口腔致病细菌与口腔-肠道-肝脏轴:对慢性肝病的新认识
Diagnostics (Basel). 2023 Oct 26;13(21):3324. doi: 10.3390/diagnostics13213324.
7
Potential Common Molecular Mechanisms Between Periodontitis and Hepatocellular Carcinoma: A Bioinformatic Analysis and Validation.牙周炎和肝细胞癌之间的潜在共同分子机制:生物信息学分析与验证。
Cancer Genomics Proteomics. 2023 Nov-Dec;20(6):602-616. doi: 10.21873/cgp.20409.
8
The association between oral and gut microbiota in male patients with alcohol dependence.酒精依赖男性患者口腔与肠道微生物群之间的关联。
Front Microbiol. 2023 Jul 28;14:1203678. doi: 10.3389/fmicb.2023.1203678. eCollection 2023.
9
Parvimonas micra can translocate from the subgingival sulcus of the human oral cavity to colorectal adenocarcinoma.小韦荣球菌可从人类口腔的龈下沟移位至结直肠腺癌。
Mol Oncol. 2024 May;18(5):1143-1173. doi: 10.1002/1878-0261.13506. Epub 2023 Sep 13.
10
Illuminating the oral microbiome and its host interactions: animal models of disease.揭示口腔微生物组及其宿主相互作用:疾病的动物模型。
FEMS Microbiol Rev. 2023 May 19;47(3). doi: 10.1093/femsre/fuad018.
非酒精性脂肪性肝病进展过程中的肠道微生物群及其代谢产物
Hepatoma Res. 2021 Jan 13;7:11. doi: 10.20517/2394-5079.2020.134. eCollection 2021.
4
Microbial adaptation to the healthy and inflamed gut environments.微生物对健康和炎症肠道环境的适应。
Gut Microbes. 2020 Nov 9;12(1):1857505. doi: 10.1080/19490976.2020.1857505.
5
Promotes the Development of Ulcerative Colitis by Inducing the Autophagic Cell Death of Intestinal Epithelial.促进溃疡性结肠炎的发展,诱导肠道上皮细胞自噬性细胞死亡。
Front Cell Infect Microbiol. 2020 Nov 27;10:594806. doi: 10.3389/fcimb.2020.594806. eCollection 2020.
6
Association between serum IgG antibody titers against and liver enzyme levels: A cross-sectional study in Sado Island.血清抗……IgG抗体滴度与肝酶水平之间的关联:佐渡岛的一项横断面研究。 (原文中“against”后面缺少具体内容)
Heliyon. 2020 Nov 18;6(11):e05531. doi: 10.1016/j.heliyon.2020.e05531. eCollection 2020 Nov.
7
Detection of Fusobaterium nucleatum in feces and colorectal mucosa as a risk factor for colorectal cancer: a systematic review and meta-analysis.检测粪便和结直肠黏膜中的 Fusobaterium nucleatum 作为结直肠癌的危险因素:系统评价和荟萃分析。
Syst Rev. 2020 Dec 3;9(1):276. doi: 10.1186/s13643-020-01526-z.
8
Nomenclature and definition of metabolic-associated fatty liver disease: a consensus from the Middle East and north Africa.代谢相关脂肪性肝病的命名与定义:中东和北非地区的共识
Lancet Gastroenterol Hepatol. 2021 Jan;6(1):57-64. doi: 10.1016/S2468-1253(20)30213-2. Epub 2020 Nov 9.
9
Oral health and salivary function in ulcerative colitis patients.溃疡性结肠炎患者的口腔健康和唾液功能。
United European Gastroenterol J. 2020 Nov;8(9):1067-1075. doi: 10.1177/2050640620957138. Epub 2020 Sep 2.
10
The Intermucosal Connection between the Mouth and Gut in Commensal Pathobiont-Driven Colitis.口腔与肠道共生菌驱动的结肠炎中的黏膜连接。
Cell. 2020 Jul 23;182(2):447-462.e14. doi: 10.1016/j.cell.2020.05.048. Epub 2020 Jun 16.